ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,898Medicare Part D Prescriptions Filled, Including Refills

Rank: 131 out of 680

$945K Total Retail Price of All Prescriptions

Rank: 92 out of 680

672 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 672 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 672 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 11,639 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 470 419 1 6
HYDROCODONE-ACETAMINOPHEN 444 412 S3 2 4
LEVOTHYROXINE SODIUM 394 352 3 2
WARFARIN SODIUM 329 285 4 20
NEXIUM 277 215 5 16
CARVEDILOL 264 215 6 23
SIMVASTATIN 237 208 7 3
AMLODIPINE BESYLATE 236 230 8 1
AZITHROMYCIN 212 181 9 42
METFORMIN HCL 184 140 10 8
DIOVAN 177 162 11 31
SERTRALINE HCL 174 126 12 28
OMEPRAZOLE 169 153 13 7
METOPROLOL TARTRATE 168 136 14 12
NAMENDA 168 167 14 35
ADVAIR DISKUS 148 127 16 53
ATORVASTATIN CALCIUM 137 113 17 11
ZOLPIDEM TARTRATE 134 99 18 17
QUETIAPINE FUMARATE 132 113 19 64
PRAVASTATIN SODIUM 127 105 20 10
DONEPEZIL HCL 125 125 21 27
LISINOPRIL 121 93 22 5
EXELON 121 121 22 112
TRAMADOL HCL 119 104 24 18
ISOSORBIDE MONONITRATE ER 116 103 25 59
AMITRIPTYLINE HCL 106 92 R 26 47
METOPROLOL SUCCINATE 106 93 26 13
PREDNISONE 104 81 28 50
ESCITALOPRAM OXALATE 103 94 29 45
CLOPIDOGREL 101 86 30 26
CITALOPRAM HBR 98 83 31 22
SPIRONOLACTONE 97 52 32 82
CYMBALTA 97 89 32 46
LANTUS 96 90 34 49
TAMSULOSIN HCL 92 81 35 34
GABAPENTIN 92 89 35 15
CELEBREX 88 77 37 90
CIPROFLOXACIN HCL 87 75 38 57
DIGOXIN 85 85 39 58
SPIRIVA 84 76 40 70
MELOXICAM 84 82 40 24
PLAVIX 82 70 42 39
MECLIZINE HCL 81 73 43 103
POTASSIUM CHLORIDE 81 53 43 14
DIOVAN HCT 81 81 43 55
BYSTOLIC 79 71 46 79
COREG CR 79 79 46 293
CLONIDINE HCL 79 75 46 36
ALENDRONATE SODIUM 78 69 49 32
HYDROCHLOROTHIAZIDE 78 61 49 9
ATENOLOL 78 72 49 19
ALBUTEROL SULFATE 75 48 52 154
PANTOPRAZOLE SODIUM 74 70 53 30
NOVOLOG 74 45 53 167
DIVALPROEX SODIUM 74 74 53 110
AMLODIPINE BESYLATE-BENAZEPRIL 73 61 56 43
LEVEMIR 72 58 57 248
LEVEMIR FLEXPEN 69 40 58 186
CRESTOR 68 31 59 25
MIRTAZAPINE 68 52 59 78
LYRICA 68 64 59 77
SEROQUEL 66 50 62 123
PHENYTOIN SODIUM EXTENDED 65 27 63 115
PREMARIN 64 63 R 64 105
RANITIDINE HCL 63 63 65 56
ETODOLAC 63 58 65 206
FLUTICASONE PROPIONATE 62 55 67 41
POLYETHYLENE GLYCOL 3350 61 55 68 62
EXFORGE 60 46 69 151
LACTULOSE 58 58 70 92
GLYBURIDE-METFORMIN HCL 57 57 R 71 107
AMOXICILLIN 57 51 71 111
METFORMIN HCL ER 57 48 71 54
CARBIDOPA-LEVODOPA 57 46 71 117
BACLOFEN 56 42 75 140
JANUVIA 55 54 76 60
MUPIROCIN 55 41 76 130
SINGULAIR 54 47 78 91
SUCRALFATE 54 33 78 160
COLCRYS 53 52 80 166
LOVAZA 52 43 81 119
TRADJENTA 51 48 82 301
GLIMEPIRIDE 50 42 83 29
ROPINIROLE HCL 50 50 83 99
SYNTHROID 50 50 83 38
SANTYL 50 50 83 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.